Kenvue (NYSE:KVUE) General Counsel Sells $679,751.06 in Stock

Kenvue Inc. (NYSE:KVUE) General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Kenvue Stock Up 1.7%

Kenvue stock traded up $0.30 during midday trading on Tuesday, hitting $17.47. 23,712,274 shares of the company’s stock were exchanged, compared to its average volume of 33,988,625. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.96. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $24.35. The firm has a 50-day moving average of $17.59 and a two-hundred day moving average of $17.27. The company has a market cap of $33.54 billion, a PE ratio of 20.55, a P/E/G ratio of 1.61 and a beta of 0.55.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.76%. The company had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $3.84 billion. During the same period in the prior year, the business earned $0.24 EPS. The firm’s quarterly revenue was up 4.5% on a year-over-year basis. As a group, analysts expect that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th will be given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 4.8%. The ex-dividend date of this dividend is Wednesday, May 13th. Kenvue’s dividend payout ratio is presently 97.65%.

Wall Street Analysts Forecast Growth

KVUE has been the subject of several analyst reports. Citigroup decreased their price target on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Zacks Research raised shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday. Barclays decreased their price target on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 14th. Jefferies Financial Group lowered shares of Kenvue from a “buy” rating to a “hold” rating and decreased their price target for the company from $23.00 to $18.00 in a research report on Friday, January 30th. Finally, UBS Group decreased their price target on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research report on Tuesday, April 7th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $19.33.

Hedge Funds Weigh In On Kenvue

Several hedge funds and other institutional investors have recently modified their holdings of the stock. PNC Financial Services Group Inc. raised its position in shares of Kenvue by 5.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 467,601 shares of the company’s stock valued at $8,061,000 after purchasing an additional 23,379 shares during the last quarter. Oslo Pensjonsforsikring AS purchased a new position in shares of Kenvue in the 1st quarter valued at approximately $467,000. Commerzbank Aktiengesellschaft FI raised its position in shares of Kenvue by 1.2% in the 1st quarter. Commerzbank Aktiengesellschaft FI now owns 79,607 shares of the company’s stock valued at $1,372,000 after purchasing an additional 939 shares during the last quarter. Meeder Advisory Services Inc. raised its position in shares of Kenvue by 52.9% in the 1st quarter. Meeder Advisory Services Inc. now owns 37,024 shares of the company’s stock valued at $638,000 after purchasing an additional 12,806 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Kenvue by 0.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 22,270,175 shares of the company’s stock valued at $383,938,000 after purchasing an additional 196,981 shares during the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.